ISRG NASDAQ pre-market $535.00 19 Jan 2026: AI investors note earnings
ISRG stock trades at $535.00 pre-market on 19 Jan 2026, down 1.17% from yesterday as volume runs at 3,015,488.00 shares. The move comes ahead of Intuitive Surgical, Inc.’s (ISRG) upcoming earnings on 22 Jan 2026, and follows mixed signals from procedure growth and product demand. Investors focused on AI-enabled medical devices should weigh near-term volatility against longer-term adoption trends in minimally invasive surgery.
ISRG stock snapshot and price action
Intuitive Surgical, Inc. (ISRG) on NASDAQ is at $535.00, down $6.34 or -1.17%, with a pre-market open of $542.00 and day range $532.63–$543.00. Market cap stands at $191,809,317,814.00 and shares outstanding are 358,476,526.00. The stock trades above its 200-day average ($514.55) but below its 50-day average ($565.13).
ISRG stock earnings and catalysts
The company reports quarterly results on 22 Jan 2026, a likely catalyst for short-term moves in ISRG stock. Recent headlines point to strong Q4 procedure growth but investor concern about order cadence and product demand. For the latest coverage see MarketBeat and MarketWatch reporting on ISRG stock developments source source.
ISRG stock valuation and fundamentals
Valuation shows a high multiple: trailing EPS is 7.55 and reported P/E is 70.87, reflecting premium expectations for growth. Revenue per share is 26.95 and free cash flow per share is 6.37, with cash per share 13.77. Profit margins remain healthy: gross margin 66.41% and net margin 28.58%, while revenue growth for FY 2024 was 17.24%.
Meyka AI rates ISRG with a score out of 100
Meyka AI rates ISRG with a score of 76.68 out of 100 (Grade B+, Suggestion: BUY). This grade factors S&P 500 comparison, sector and industry performance, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a 1-year target of $584.28 (implied upside 9.21% vs $535.00) and a monthly target of $632.22 (implied near-term upside 18.17%). Forecasts are model-based projections and not guarantees.
ISRG stock technicals and trading setup
Technical indicators show momentum but some overbought readings. RSI is 65.69, MACD histogram is 0.11, and ADX is 22.53, suggesting a mild uptrend. Bollinger middle band sits at $566.22 and ATR is 11.47, implying intraday swings around low double-digit dollars. Average volume is 2,008,090.00, and today’s volume is elevated at 3,015,488.00.
Risks and opportunities for ISRG stock
Opportunities: continued adoption of da Vinci systems, the Ion diagnostic platform, recurring consumables, and digital services support margin expansion and cash flow. Risks: high valuation (P/E 70.87), sensitivity to procedure volumes, competitive pressure in robotics, and potential reimbursement or regulatory shifts. Watch procedure trends, orders backlog, and guidance in the earnings release.
Final Thoughts
ISRG stock offers a mix of stable fundamentals and premium valuation. At $535.00 pre-market on 19 Jan 2026, the company shows solid margins, robust cash per share, and FY 2024 revenue growth of 17.24%, but trades at a high P/E of 70.87. Meyka AI’s model projects a 1-year target of $584.28, implying an upside of 9.21% versus the current price, while a monthly model target of $632.22 implies 18.17% near-term upside. Investors focused on AI-driven medical devices should weigh these modeled gains against valuation risk and earnings execution on 22 Jan 2026. Use the upcoming report to assess procedure growth, order trends, and management guidance before adjusting position sizes. This analysis is for informational purposes; Meyka AI is an AI-powered market analysis platform and not a registered investment advisor.
FAQs
What is the current price and intraday move for ISRG stock?
ISRG stock trades at $535.00 pre-market on 19 Jan 2026, down 1.17% with volume at 3,015,488.00 shares and a daily range of $532.63–$543.00.
When does Intuitive Surgical report earnings and why it matters for ISRG stock?
Intuitive Surgical reports on 22 Jan 2026. Earnings will update guidance, procedure trends, and product demand data that typically drive short-term moves in ISRG stock.
What valuation and financials should investors watch for ISRG stock?
Key metrics include P/E 70.87, EPS 7.55, free cash flow per share 6.37, and revenue growth 17.24%. High multiples reflect growth expectations and increase sensitivity to missed guidance.
What rating and target does Meyka AI assign to ISRG stock?
Meyka AI assigns ISRG a 76.68/100 score (Grade B+, Suggestion: BUY). The 1-year forecast is $584.28, implying 9.21% upside versus $535.00. Forecasts are model-based and not guarantees.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
